Related Experiment Video
Updated: Aug 21, 2026
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Novel approaches to the treatment of non-small cell lung cancer
Carlos G Ferreira1, Cynthia Huisman, Giuseppe Giaccone
1Department of Medical Oncology, Academic Hospital Vrije Universiteit, Amsterdam, The Netherlands.
Abstract:
Prognosis of non-small cell lung carcinomas (NSCLC) remains poor, especially in advanced disease. The introduction of new cytotoxic agents in the past decade did only attain minor improvements in survival. It is rather clear that chemotherapy may have reached a plateau, and that it will be difficult to obtain better results in advanced NSCLC by chemotherapy alone. Novel treatment modalities are urgently needed in advanced NSCLC. Backed-up by advances in the understanding of tumor cell biology, a new generation of anticancer agents specifically directed at targets such as tyrosine kinases, farnesyl transferase, angiogenesis factors, matrixmetalloproteinases and oncogenes has been developed in recent years. In this review, we give a brief summary of the state-of-the-art treatment of NSCLC, highlighting its limitations. Novel systemic approaches are then discussed in detail with focus on their mechanistic rationale, stage of clinical development and possible drawbacks. Finally, perspectives of future applications and impact on the treatment of NSCLC are also discussed.
Insights
Advanced non-small cell lung cancer (NSCLC) treatment needs novel therapies as chemotherapy has plateaued. This review explores new targeted treatments and their potential impact on improving patient survival in advanced NSCLC.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Prognosis for non-small cell lung cancer (NSCLC) is poor, particularly in advanced stages.
- Chemotherapy offers limited survival benefits and has reached a plateau in efficacy.
- Novel therapeutic strategies are essential for improving outcomes in advanced NSCLC.
Purpose of the Study:
- To review the current state of NSCLC treatment, emphasizing its limitations.
- To discuss novel systemic treatment modalities for advanced NSCLC.
- To explore the mechanistic rationale, clinical development, and potential drawbacks of emerging therapies.
Main Methods:
- Literature review of state-of-the-art NSCLC treatments.
- Detailed discussion of novel systemic approaches targeting specific molecular pathways.
- Analysis of clinical development stages and future perspectives.
Main Results:
- Chemotherapy has shown minimal improvements in survival for advanced NSCLC.
- New targeted agents focus on tyrosine kinases, farnesyl transferase, angiogenesis, matrix metalloproteinases, and oncogenes.
- These novel agents represent a new generation of anticancer therapies.
Conclusions:
- Novel treatment modalities are urgently needed for advanced NSCLC.
- Targeted therapies offer promising alternatives to conventional chemotherapy.
- Future research and application of these novel agents may significantly impact NSCLC treatment outcomes.
Related Concept Videos
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...